Tech Company Financing Transactions

Adcendo Funding Round

Adcendo, based in Copenhagen, secured $33.8 million in investment from Gilde Healthcare Partners, Healthcap Venture Capital and Novo Holdings.

Transaction Overview

Company Name
Announced On
4/4/2023
Transaction Type
Venture Equity
Amount
$33,832,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to initiate a broad clinical development program for uPARAP ADC in Sarcoma and is also planning to advance the development of its 2nd ADC pipeline asset with Development Candidate Nomination (DCN) planned in H1 2024.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
BioInnovation Institute, Ole Maaløes Vej 3, Copenhagen, Capi
Copenhagen, 2200
DK
Phone
Undisclosed
Email Address
Overview
Adcendo ApS is a Copenhagen-based biotech company dedicated to developing highly differentiated antibody-drug conjugates (ADCs) for the treatment of underserved cancers. Antibody-drug conjugates (ADCs) represent an emerging drug modality, directing anticancer therapeutics to malignant cells overexpressing particular surface target molecules. 10+ ADCs are now in routine clinical use for cancer patients, with many more novel ADC assets currently investigated in clinical studies in solid tumors and hematologic malignancies
Profile
Adcendo LinkedIn Company Profile
Social Media
Adcendo Company Twitter Account
Company News
Adcendo News
Facebook
Adcendo on Facebook
YouTube
Adcendo on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Pehl
  Michael Pehl LinkedIn Profile  Michael Pehl Twitter Account  Michael Pehl News  Michael Pehl on Facebook
Chief Operating Officer
Christoffer Nielsen
  Christoffer Nielsen LinkedIn Profile  Christoffer Nielsen Twitter Account  Christoffer Nielsen News  Christoffer Nielsen on Facebook
Chief Scientific Officer
Dominik Mumberg
  Dominik Mumberg LinkedIn Profile  Dominik Mumberg Twitter Account  Dominik Mumberg News  Dominik Mumberg on Facebook
Chief Technical Officer
Pernille Hemmingsen
  Pernille Hemmingsen LinkedIn Profile  Pernille Hemmingsen Twitter Account  Pernille Hemmingsen News  Pernille Hemmingsen on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/4/2023: Everstream Analytics venture capital transaction
Next: 4/4/2023: Trustle venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary